Humanigen Statistics
Total Valuation
Humanigen has a market cap or net worth of $23,816. The enterprise value is -$3.07 million.
| Market Cap | 23,816 |
| Enterprise Value | -3.07M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 10.35% |
| Owned by Institutions (%) | 0.49% |
| Float | 110.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 9.39 |
| PS Ratio | 0.01 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.09
| Current Ratio | 0.09 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -23.36 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -233.90% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $283,167 |
| Profits Per Employee | -$8.94M |
| Employee Count | 6 |
| Asset Turnover | 0.07 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.87% in the last 52 weeks. The beta is -1.05, so Humanigen's price volatility has been lower than the market average.
| Beta (1Y) | -1.05 |
| 52-Week Price Change | -99.87% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 47.02 |
| Average Volume (30 Days) | n/a |
Short Selling Information
| Short Interest | 3.60M |
| Short Previous Month | 3.32M |
| Short % of Shares Out | n/a |
| Short % of Float | 3.26% |
| Short Ratio (days to cover) | 1.52 |
Income Statement
In the last 12 months, Humanigen had revenue of $1.70 million and -$53.63 million in losses. Loss per share was -$0.54.
| Revenue | 1.70M |
| Gross Profit | 1.70M |
| Operating Income | -52.01M |
| Pretax Income | -53.63M |
| Net Income | -53.63M |
| EBITDA | -51.43M |
| EBIT | -51.43M |
| Loss Per Share | -$0.54 |
Balance Sheet
The company has $3.10 million in cash and no debt, giving a net cash position of $3.10 million.
| Cash & Cash Equivalents | 3.10M |
| Total Debt | n/a |
| Net Cash | 3.10M |
| Net Cash Per Share | n/a |
| Equity / Book Value | -49.73M |
| Book Value Per Share | n/a |
| Working Capital | -48.27M |
Cash Flow
| Operating Cash Flow | -64.32M |
| Capital Expenditures | n/a |
| Free Cash Flow | -64.32M |
| FCF Per Share | -$0.54 |
Margins
Gross margin is 100.00%, with operating and profit margins of -3,061.21% and -3,156.80%.
| Gross Margin | 100.00% |
| Operating Margin | -3,061.21% |
| Pretax Margin | -3,156.80% |
| Profit Margin | -3,156.80% |
| EBITDA Margin | -3,027.19% |
| EBIT Margin | -3,027.19% |
| FCF Margin | -3,785.46% |
Dividends & Yields
Humanigen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -81.55% |
| Shareholder Yield | -81.55% |
| Earnings Yield | -225,201.55% |
| FCF Yield | -270,049.55% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on September 14, 2020. It was a reverse split with a ratio of 1:5.
| Last Split Date | Sep 14, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:5 |
Scores
Humanigen has an Altman Z-Score of -231.89 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -231.89 |
| Piotroski F-Score | 1 |